AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8811478
Drug: Complex therapy
RxNorm normalized name: hesperidin complex
DrugBank: Citrus bioflavonoids (DB14586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complex therapy
Trial: 9894374
Drug: Amlodipine 5
RxNorm normalized name: amlodipine 5 MG
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine 5 mg (increased to 10 mg if necessary)
Trial: 12544672
Drug: Transdermal progesterone
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Transdermal progesterone cream (32 mg daily)
Trial: 10430149
Drug: Orally administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orally administered sonographic contrast agent (200, 400, 600, 800, or 1000 ml)
Trial: 18044102
Drug: Racemic albuterol
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Racemic albuterol
Trial: 28052570
Drug: Youth Fit
RxNorm normalized name: influenza A virus A/South Australia/34/2019 (H3N2) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Youth Fit 4 Life (YF4L) treatment group
Trial: 11253857
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of rate control and anticoagulation with cardioversion if AF persists
Trial: 26704612
Drug: Tetravalent dengue
RxNorm normalized name: dengue virus live antigen, CYD serotype 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetravalent dengue vaccine candidate (TDV)
Trial: 26646759
Drug: Afatinib plus
RxNorm normalized name: Afatinib
DrugBank: Afatinib (DB08916)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Afatinib plus paclitaxel (40 mg/day; 80 mg/m²/week)
Trial: 11315234
Drug: Tiludronate 200
RxNorm normalized name: tiludronate 200 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiludronate 200 mg/day
Trial: 7747617
Drug: Tiludronate 400
RxNorm normalized name: tiludronate
DrugBank: Tiludronic acid (DB01133)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tiludronate 400 mg/day
Trial: 2282920
Drug: Felodipine 5
RxNorm normalized name: felodipine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine 5 mg twice daily for 2 weeks
Trial: 11103054
Drug: Epoetin alfa
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epoetin alfa low-dose (20,000 U)
Trial: 26575158
Drug: End of
RxNorm normalized name: End-Zit
DrugBank: Octasulfur (DB09353)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: End of therapy HADS-D
Trial: 20370840
Drug: Inhaled insulin
RxNorm normalized name: insulin, regular, human Inhalation Powder [Afrezza]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled insulin therapy
Trial: 8546737
Drug: 1 mg/day
RxNorm normalized name: Lyllana 0.1 MG/Day Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/day oral bovine type II collagen (n = 30)
Trial: 8096670
Drug: Beta blockers
RxNorm normalized name: BETA BLOCKERS/RELATED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta blockers alone
Trial: 19647928
Drug: Intravenous thrombolysis
RxNorm normalized name: thrombocytin
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous thrombolysis (rtPA)
Trial: 12740311
Drug: Alcohol-displacement (A)
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol-displacement (A) diet (1.5 g/kg alcohol displacing CHO energy from control)
Trial: 31736269
Drug: Dexamethasone implant
RxNorm normalized name: dexamethasone Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone implant (Ozurdex)
Trial: 8976353
Drug: Vein Patch
RxNorm normalized name: Sus scrofa vein preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vein Patch Closure (SVP)
Trial: 26669916
Drug: Adalimumab (ADA)
RxNorm normalized name: Adalimumab
DrugBank: Adalimumab (DB00051)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Adalimumab (ADA) monotherapy
Trial: 17786886
Drug: Other mood
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other mood stabilizers and antidepressants
Trial: 22241281
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg haloperidol
Trial: 25226311
Drug: Citrulline malate
RxNorm normalized name: CITRULLINE MALATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citrulline malate (8 g)
Trial: 30385039
Drug: Low-dose prednisone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose prednisone plus enteric-coated mycophenolate sodium
Trial: 17097995
Drug: Five bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Five bolus doses of daclizumab
Trial: 8548226
Drug: Iron saccharate
RxNorm normalized name: Iron saccharate
DrugBank: Iron sucrose (DB09146)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron saccharate 200 mg/day intravenously for 12 consecutive days
Trial: 24569099
Drug: Twice-daily perphenazine
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily perphenazine dosing
Trial: 18379357
Drug: Vandetanib 200
RxNorm normalized name: Vandetanib
DrugBank: Vandetanib (DB05294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vandetanib 200 mg
Trial: 19332730
Drug: Vandetanib 300
RxNorm normalized name: vandetanib 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vandetanib 300 mg
Trial: 24385118
Drug: Topical cosmetic
RxNorm normalized name: Botox Cosmetic
DrugBank: DaxibotulinumtoxinA (DB17929)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical cosmetic formulation
Trial: 7758556
Drug: Baclofen 25
RxNorm normalized name: baclofen 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baclofen 25 mg before sleep
Trial: 23702435
Drug: Sublingual ketorolac
RxNorm normalized name: ketorolac Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual ketorolac (0.5 mg/kg)
Trial: 9856522
Drug: Intramuscular vaccination
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular vaccination
Trial: 14685040
Drug: Hyposensitization therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyposensitization therapy (duration not specified).
Trial: 3496186
Drug: Both formulations
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both formulations (enteric-coated and plain)
Trial: 3675695
Drug: Amoxicillin 1000
RxNorm normalized name: amoxicillin 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 1000 mg p.o.t.i.d.
Trial: 17668348
Drug: Cocaethylene infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cocaethylene infusion at 0 ng/mL (placebo)
Trial: 8646474
Drug: Corticosteroid injections
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid injections
Trial: 3315270
Drug: 2000 hr
RxNorm normalized name: sulfalene 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2000 hr dosing of Armophylline (600-900 mg/24 hr)
Trial: 7760967
Drug: T3 therapy
RxNorm normalized name: tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: T3 therapy (75-100 micrograms T3 daily)
Trial: 12368690
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin (IVIG) 1 g/kg/dose x2
Trial: 21542914
Drug: Hip school
RxNorm normalized name: HIP
DrugBank: Heme iron polypeptide (DB11067)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hip school + Manual therapy (group B)
Trial: 8560161
Drug: Intranasal immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal immunotherapy with Dermatophagoides extract
Trial: 15030340
Drug: Bexarotene gel
RxNorm normalized name: Bexarotene
DrugBank: Bexarotene (DB00307)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Bexarotene gel monotherapy
Trial: 31860632
Drug: Oral flurbiprofen
RxNorm normalized name: Flurbiprofen
DrugBank: Flurbiprofen (DB00712)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral flurbiprofen
Trial: 26203169
Drug: Deworming drugs
RxNorm normalized name: oxfendazole
DrugBank: Oxfendazole (DB11446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deworming drugs
Trial: 8045623
Drug: Traditional therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional therapies
Trial: 30523659
Drug: Hybrid intervention
RxNorm normalized name: Amaranthus hybridus pollen
DrugBank: Amaranthus hybridus pollen (DB15503)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hybrid intervention combining exergaming and physical therapy
Trial: 9631990
Drug: Fluconazole 150
RxNorm normalized name: fluconazole 150 MG
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole 150 mg
Trial: 9631990
Drug: Fluconazole 450
RxNorm normalized name: Fluconazole
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole 450 mg
Trial: 10830739
Drug: Non-randomized treatment
RxNorm normalized name: jojoba oil, randomized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-randomized treatment group
Trial: 10830739
Drug: Randomized treatment
RxNorm normalized name: jojoba oil, randomized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Randomized treatment group
Trial: 6274503
Drug: Hyperthermia combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperthermia combined with high-dose-rate external beam radiotherapy
Trial: 7789550
Drug: Nal-Glu 100
RxNorm normalized name: Glu
DrugBank: gamma-Glutamylcysteine (DB03408)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nal-Glu 100 micrograms/kg per day + T enanthate 50 mg IM weekly
Trial: 30321655
Drug: Placebo (twice-daily)
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Placebo (twice-daily)
Trial: 16418021
Drug: 30 mL
RxNorm normalized name: Vial M/T 30 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mL of ropivacaine (150 mg)
Trial: 25818103
Drug: Regular oral
RxNorm normalized name: infant formula,regular ORAL PACKET (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular oral instructions (Control group).
Trial: 19151299
Drug: Gabapentin 1200-1600
RxNorm normalized name: Gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gabapentin 1200-1600 mg
Trial: 10665617
Drug: Testosterone administration
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone administration (sublingual)
Trial: 9332680
Drug: Zorubicin 325
RxNorm normalized name: zorubicin
DrugBank: Zorubicin (DB11618)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zorubicin 325 mg/m2, day 1 (Group A)
Trial: 9332680
Drug: Zorubicin 250
RxNorm normalized name: zorubicin
DrugBank: Zorubicin (DB11618)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zorubicin 250 mg/m2, day 1 and cisplatin 30 mg/m2, days 2-5 (Group B)
Trial: 9511041
Drug: Doxycycline therapy
RxNorm normalized name: Doxycycline
DrugBank: Doxycycline (DB00254)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Doxycycline therapy for 4 months
Trial: 9141518
Drug: Finasteride 5
RxNorm normalized name: finasteride 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finasteride 5 mg
Trial: 31221280
Drug: Normal sodium
RxNorm normalized name: sulfacetamide sodium Medicated Pad [Rosula NS]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal sodium diet (NS: 7 g/day of dietary sodium chloride)
Trial: 15619680
Drug: Alendronate 70
RxNorm normalized name: ALENDRONATE 70MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 70 mg once weekly
Trial: 8751522
Drug: High-dose aprotinin
RxNorm normalized name: Aprotinin
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-dose aprotinin
Trial: 24586717
Drug: First dose
RxNorm normalized name: Cow first milk
DrugBank: Bos taurus colostrum (DB19249)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First dose of MR vaccine administered at 8 months and second dose of MMR vaccine administered at 18-24 months
Trial: 30196900
Drug: 100 g
RxNorm normalized name: Berri-Freez 4.5 GM per 100 GM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 g sucrose
Trial: 27382812
Drug: Intrathecal Fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intrathecal Fentanyl (25 µg) added to bupivacaine (10mg)
Trial: 28937845
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate MDI 320 mcg (80 mcg/inhalation, 4 inhalations)
Trial: 30466512
Drug: NT-proBNP-guided therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NT-proBNP-guided therapy
Trial: 31976786
Drug: Cisplatin 25
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin 25 mg/m2 and gemcitabine 600 mg/m2 intravenously on days 3 and 10; plus veliparib 80 mg orally twice per day on days 1 to 12, cycled every 3 weeks (Arm A)
Trial: 31976786
Drug: Cisplatin 25
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin 25 mg/m2 and gemcitabine 600 mg/m2 intravenously on days 3 and 10 (Arm B)
Trial: 8554083
Drug: Low-dose levodopa
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose levodopa and carbidopa
Trial: 20978247
Drug: Sugammadex 2
RxNorm normalized name: sugammadex 200 MG in 2 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex 2 mg/kg
Trial: 23549151
Drug: Oral immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral immunotherapy (OIT) for the treatment of food allergy
Trial: 26945662
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg Finasteride daily for 2 weeks before TURP
Trial: 11336101
Drug: Fluvastatin extended-release
RxNorm normalized name: Fluvastatin Extended-Release Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin extended-release 320 mg
Trial: 9601592
Drug: Bupivacaine gel
DrugBank: Bupivacaine (DB00297)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupivacaine gel (2.5 mg/ml)
Trial: 10807025
Drug: Treatment intensity
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment intensity in the last month of life for all age groups
Trial: 17563309
Drug: Inhaled insulin
RxNorm normalized name: insulin, regular, human Inhalation Powder [Afrezza]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled insulin
Trial: 25643864
Drug: Mind Reading
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mind Reading and in vivo rehearsal treatment
Trial: 12660911
Drug: Randomized placebo-controlled
RxNorm normalized name: jojoba oil, randomized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Randomized placebo-controlled trial of an injectable medicine given throughout pregnancy
Trial: 9135193
Drug: 0.1 mg
RxNorm normalized name: biotin 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg intrathecal morphine
Trial: 14747881
Drug: Valsartan 160
RxNorm normalized name: valsartan 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan 160 mg o.d.
Trial: 19446324
Drug: Early exercise
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early exercise and mobilisation (physical and occupational therapy) during periods of daily interruption of sedation
Trial: 1647193
Drug: Granisetron and
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Granisetron and Lorazepam (in combination)
Trial: 25008878
Drug: Intratracheal injection
RxNorm normalized name: Intratracheal Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intratracheal injection of porcine pulmonary surfactant (PS)
Trial: 20473044
Drug: Gabapentin 300
RxNorm normalized name: gabapentin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 300 mg/d
Trial: 19149900
Drug: Trivalent inactivated
RxNorm normalized name: diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tdvax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trivalent inactivated split virus influenza vaccine (TIV)
Trial: 26422093
Drug: Esomeprazole 10
RxNorm normalized name: esomeprazole 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 10 mg (for children > 20 kg)
Trial: 2265237
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg PPA HCl CR caplet once daily for 4 days
Trial: 31244327
Drug: Integrated programme
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Integrated programme of physical and electrical therapy
Trial: 17130031
Drug: Group A
RxNorm normalized name: Blood group A IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A (n = 38) received 1 g paracetamol and 100 mg diclofenac
Trial: 8565027
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone 10 mg once daily in the morning
Trial: 1385913
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (group C)
Trial: 3028456
Drug: Enalapril maleate
RxNorm normalized name: Enalapril Maleate
DrugBank: Enalapril (DB00584)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enalapril maleate 10 mg
Trial: 25599738
Drug: Routine anti-rejection
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine anti-rejection medication only (n = 32)
Trial: 11085197
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) administration
Trial: 20558755
Drug: L-NAME +
RxNorm normalized name: L-NAME
DrugBank: N-omega-nitro-L-arginine methyl ester (DB12750)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NAME + ketorolac infusion
Trial: 29249276
Drug: Adjunctive rifampicin
RxNorm normalized name: rifampicin
DrugBank: Rifampin (DB01045)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adjunctive rifampicin
Trial: 18211754
Drug: Sublingual immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual immunotherapy (SLIT) with 'Dermatophagoides Farinae Drops' (n = 139)
Trial: 24200231
Drug: 3% diquafosol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3% diquafosol ophthalmic solution
Trial: 6110436
Drug: Propranolol 40
RxNorm normalized name: propranolol 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 40 mg four times daily for 1 week (alone)
Trial: 22520733
Drug: Metronomic chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronomic chemotherapy combined with bevacizumab and erlotinib
Trial: 28074421
Drug: Directly observed
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Directly observed combination antiretroviral therapy (DOT-cART)
Trial: 30333315
Drug: Ketoprofen 75
RxNorm normalized name: ketoprofen 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen 75 mg by mouth 3 times daily for 4 months
Trial: 29193743
Drug: Specialized Early
RxNorm normalized name: epinephrine / mepivacaine hydrochloride Injectable Solution [Scandonest 2% Special]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specialized Early Intervention (SEI) treatment (OPUS treatment)
Trial: 12547469
Drug: Selegiline hydrochloride
RxNorm normalized name: Selegiline Hydrochloride
DrugBank: Selegiline (DB01037)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Selegiline hydrochloride (5 mg p.o. twice daily)
Trial: 7488417
Drug: Granisetron alone
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Granisetron alone (group G)
Trial: 18685511
Drug: Synbiotic formulation
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Synbiotic formulation A (3 probiotic strains and FOS)
Trial: 1304727
Drug: 0.15 mg
RxNorm normalized name: iodine 0.15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.15 mg of oral clonidine
Trial: 25140469
Drug: Right internal
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Right internal thoracic artery (RITA) pedicled to LAD and left internal thoracic artery (LITA) pedicled to circumflex in Group-2 (G-2)
Trial: 26582579
Drug: Natural mineral
RxNorm normalized name: ZINC OXIDE 8.25 g in 44 mL TOPICAL LOTION [Natural Mineral Formula]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natural mineral water (500 mL)